| |
|
|
|
|
|
|
|
|
1. |
Record Nr. |
UNINA990000731210403321 |
|
|
Autore |
Jacobus, John |
|
|
Titolo |
Twentieth-century architecture : the middle years 1940-65 / John Jacobus |
|
|
|
|
|
|
|
Pubbl/distr/stampa |
|
|
London : Thames and Hudson, 1966 |
|
|
|
|
|
|
|
Descrizione fisica |
|
|
|
|
|
|
Locazione |
|
|
|
|
|
|
|
|
Collocazione |
|
ARCH B 402 |
C 786 CAN |
RGT 383 |
|
|
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
|
|
|
|
|
|
|
2. |
Record Nr. |
UNINA9910980035103321 |
|
|
Autore |
Lewiecki E. Michael |
|
|
Titolo |
Current concepts for the management of patients with osteoporosis / / E. Michael Lewiecki |
|
|
|
|
|
|
|
Pubbl/distr/stampa |
|
|
London, : Henry Stewart Talks, 2022 |
|
|
|
|
|
|
|
Descrizione fisica |
|
1 online resource (1 streaming video file (35 min.) : color, sound) |
|
|
|
|
|
|
Collana |
|
Bone in health and disease : bone physiology and osteoporosis, , 2056-452X |
Periodic reports : advances in clinical interventions and research platforms, , 2056-452X |
Small molecule drug discovery, , 2056-452X |
|
|
|
|
|
|
|
|
Soggetti |
|
Bones - Diseases |
Osteoporosis - Chemotherapy |
Osteoporosis - Diagnosis |
Osteoporosis - Treatment |
Bone and Bones |
Bone Density Conservation Agents - therapeutic use |
Bone Density - drug effects |
Bone Diseases - drug therapy |
Disease Management |
Osteoporosis - diagnosis |
Osteoporosis - drug therapy |
Osteoporosis - prevention & control |
Osteoporosis - therapy |
Osteoporosis, Postmenopausal |
Osteoporotic Fractures - prevention & control |
Precision Medicine |
Risk Factors |
|
|
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Videoregistrazione |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Note generali |
|
Animated audio-visual presentation with synchronized narration. |
Title from title frames. |
|
|
|
|
|
|
|
|
|
|
|
|
Nota di contenuto |
|
Contents: History of osteoporosis care -- Assessment of fracture risk -- Imminent fracture risk -- Individualized treatment -- Sequence of therapy -- Treat-to-target -- Technology-enabled collaborative learning. |
|
|
|
|
|
|
|
| |